Anti-Human RHD Recombinant Antibody (Atorolimumab) (CAT#: TAB-149)

Recombinant monoclonal antibody to RhD. Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG3
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
  • CAS
  • 202833-08-7
  • Generic Name
  • Atorolimumab
  • Related Disease
  • Unknown

Product Property

  • Purity
  • >95%, by SDS-PAGE with silver staining, under reducing conditions.
  • Storage
  • At -20°C for one year.

Target

  • Alternative Names
  • Atorolimumab;202833-08-7;RHD;Rh blood group, D antigen;RH, Rhesus blood group, D antigen;blood group Rh(D) polypeptide;CD240D;DIIIc;Rh4;Rh30a;RhII;RhPI;D antigen (DCS);RH polypeptide 2;rhesus D antigen;Rhesus system D polypeptide;Rh blood group antigen Ev

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Atorolimumab"

Afuco™ Anti-RHD ADCC Recombinant Antibody (Atorolimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RhD. Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.

See other products for "RHD"

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-243 Afuco™ Anti-RHD ADCC Recombinant Antibody (Morolimumab), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody
AFC-TAB-460CQ Afuco™ Anti-RHD ADCC Recombinant Antibody (Roledumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, Inhib ADCC enhanced antibody
AFC-TAB-149 Afuco™ Anti-RHD ADCC Recombinant Antibody (Atorolimumab), ADCC Enhanced ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-149. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare